Search results for undefined[Clear]
3 results found
Abbvie has withdrawn the antitrust paperwork for its $63 billion purchase of Allergan with the US Federal Trade Commission, MLex has learned.
The federal judge who approved T-Mobile's plan to buy Sprint said the usual presumptions in antitrust law don't work in this case because of the specifics of the dynamic, rapidly changing mobile wireless industry.
Since a recent change in policy by the US Department of Justice to streamline merger reviews, all new investigations are on track for closing within six months, a senior DOJ official said.